News headlines about Align Technology (NASDAQ:ALGN) have trended somewhat positive on Tuesday, Accern reports. The research firm rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Align Technology earned a news sentiment score of 0.12 on Accern’s scale. Accern also assigned media stories about the medical equipment provider an impact score of 46.1438708216959 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
These are some of the media stories that may have effected Accern’s scoring:
- Align Technology (ALGN) Expected to Post Quarterly Sales of $408.25 Million (americanbankingnews.com)
- Analysts Expect Align Technology (ALGN) Will Post Earnings of $0.98 Per Share (americanbankingnews.com)
- Should You Buy Align Technology Inc (NASDAQ:ALGN) Now? (finance.yahoo.com)
- 9 Stocks Fueled By High-Octane Sales Growth (finance.yahoo.com)
A number of equities analysts have recently issued reports on the stock. Zacks Investment Research upgraded shares of Align Technology from a “hold” rating to a “buy” rating and set a $272.00 target price on the stock in a research report on Wednesday, April 4th. Vetr upgraded shares of Align Technology from a “buy” rating to a “strong-buy” rating and set a $302.42 target price on the stock in a research report on Monday, March 26th. BidaskClub upgraded shares of Align Technology from a “hold” rating to a “buy” rating in a research report on Saturday, March 10th. Barclays began coverage on shares of Align Technology in a research report on Thursday, March 8th. They set an “overweight” rating and a $290.00 target price on the stock. Finally, ValuEngine upgraded shares of Align Technology from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. Align Technology presently has an average rating of “Buy” and an average target price of $260.49.
NASDAQ:ALGN traded up $6.33 during trading hours on Tuesday, hitting $271.83. The stock had a trading volume of 617,950 shares, compared to its average volume of 1,086,520. Align Technology has a one year low of $114.74 and a one year high of $287.32. The company has a market capitalization of $20,975.28, a PE ratio of 69.70, a PEG ratio of 1.98 and a beta of 1.47.
Align Technology (NASDAQ:ALGN) last issued its earnings results on Tuesday, January 30th. The medical equipment provider reported $1.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.96 by $0.23. Align Technology had a net margin of 15.71% and a return on equity of 28.55%. The firm had revenue of $421.30 million during the quarter, compared to the consensus estimate of $395.88 million. During the same quarter in the prior year, the firm earned $0.59 earnings per share. The business’s quarterly revenue was up 43.7% on a year-over-year basis. equities analysts forecast that Align Technology will post 4.52 earnings per share for the current year.
In related news, insider Joseph M. Hogan acquired 1,500 shares of the stock in a transaction dated Tuesday, February 13th. The stock was bought at an average price of $233.63 per share, with a total value of $350,445.00. Following the completion of the transaction, the insider now directly owns 42,984 shares of the company’s stock, valued at $10,042,351.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Emory Wright sold 45,780 shares of the stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $260.08, for a total transaction of $11,906,462.40. Following the sale, the vice president now directly owns 29,957 shares of the company’s stock, valued at approximately $7,791,216.56. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by corporate insiders.
Align Technology Company Profile
Align Technology, Inc designs, manufactures, and markets a system of clear aligner therapy, intraoral scanners, and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services. The company's Clear Aligner segment offers Invisalign Full, a treatment used for a range of malocclusion; Invisalign Teen treatment that addresses orthodontic needs of teenage patients, such as compliance indicators, compensation for tooth eruption, and six free single arch replacement aligners; and Invisalign Assist treatment for anterior alignment and aesthetically-oriented cases.
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.